Drugs Made In America Acquisition Corp
DMAAU10.490USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Drugs Made In America Acquisition Corp Company
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corp Info
Ticker SymbolDMAAU
Company nameDrugs Made In America Acquisition Corp
IPO dateJan 28, 2025
CEOStockwell (Lynn)
Number of employees- -
Security typeUnit
Fiscal year-end- -
Address1 East Broward Boulevard
CityFT LAUDERDALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33301
Phone19548703099
Website
Ticker SymbolDMAAU
IPO dateJan 28, 2025
CEOStockwell (Lynn)
Company Executives of Drugs Made In America Acquisition Corp
Name
Name/Position
Position
Shareholding
Change
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.28%
Wolverine Asset Management, LLC
0.55%
RiverNorth Capital Management LLC
0.44%
Clear Street Group Inc
0.20%
Other
79.65%
Shareholders
Shareholders
Proportion
Drugs Made In America Acquisition LLC
17.88%
Kryger Capital Limited
1.28%
Wolverine Asset Management, LLC
0.55%
RiverNorth Capital Management LLC
0.44%
Clear Street Group Inc
0.20%
Other
79.65%
Shareholder Types
Shareholders
Proportion
Corporation
17.88%
Investment Advisor
1.56%
Investment Advisor/Hedge Fund
0.65%
Hedge Fund
0.61%
Research Firm
0.20%
Other
79.11%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
21
706.12K
14.40%
--
2025Q3
21
706.12K
14.40%
-280.00K
2025Q2
19
986.13K
14.72%
-2.41M
2025Q1
19
3.40M
0.80%
+3.21M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
--
--
Jun 30, 2025
RiverNorth Capital Management LLC
420.50K
1.79%
--
--
Jun 30, 2025
Clear Street LLC
45.92K
0.2%
+40.07K
+685.09%
Jun 30, 2025
Robinson Capital Management, LLC
30.00K
0.13%
+20.00K
+200.00%
Jun 30, 2025
Tuttle Capital Management, LLC
20.00K
0.09%
-20.00K
-50.00%
Jun 30, 2025
UBS Financial Services, Inc.
18.39K
0.08%
+107.00
+0.59%
Jun 30, 2025
Citadel Advisors LLC
14.03K
0.06%
-1.73K
-10.96%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
0%
RiverNorth Enhanced Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
Proportion0%
SPAC and New Issue ETF
Proportion0%
RiverNorth Enhanced Pre-Merger SPAC ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Drugs Made In America Acquisition Corp?
The top five shareholders of Drugs Made In America Acquisition Corp are:
Drugs Made In America Acquisition LLC holds 4.19M shares, accounting for 17.88% of the total shares.
Wolverine Asset Management, LLC holds 130.00K shares, accounting for 0.55% of the total shares.
RiverNorth Capital Management LLC holds 420.50K shares, accounting for 1.79% of the total shares.
Clear Street LLC holds 45.92K shares, accounting for 0.20% of the total shares.
Robinson Capital Management, LLC holds 30.00K shares, accounting for 0.13% of the total shares.
Drugs Made In America Acquisition LLC holds 4.19M shares, accounting for 17.88% of the total shares.
Wolverine Asset Management, LLC holds 130.00K shares, accounting for 0.55% of the total shares.
RiverNorth Capital Management LLC holds 420.50K shares, accounting for 1.79% of the total shares.
Clear Street LLC holds 45.92K shares, accounting for 0.20% of the total shares.
Robinson Capital Management, LLC holds 30.00K shares, accounting for 0.13% of the total shares.
What are the top three shareholder types of Drugs Made In America Acquisition Corp?
The top three shareholder types of Drugs Made In America Acquisition Corp are:
Drugs Made In America Acquisition LLC
Kryger Capital Limited
Wolverine Asset Management, LLC
Drugs Made In America Acquisition LLC
Kryger Capital Limited
Wolverine Asset Management, LLC
How many institutions hold shares of Drugs Made In America Acquisition Corp (DMAAU)?
As of 2025Q4, 21 institutions hold shares of Drugs Made In America Acquisition Corp, with a combined market value of approximately 706.12K, accounting for 14.40% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Drugs Made In America Acquisition Corp?
In --, the -- business generated the highest revenue for Drugs Made In America Acquisition Corp, amounting to -- and accounting for --% of total revenue.
